Select Publications
Journal articles
2015, 'Neuronal control of bone and muscle', Bone, 80, pp. 95 - 100, http://dx.doi.org/10.1016/j.bone.2015.05.006
,2015, 'Vitamin D, muscle and bone: Integrating effects in development, aging and injury', Molecular and Cellular Endocrinology, 410, pp. 3 - 10, http://dx.doi.org/10.1016/j.mce.2015.03.020
,2015, 'NPY signalling in early osteoblasts controls glucose homeostasis', Molecular Metabolism, 4, pp. 164 - 174, http://dx.doi.org/10.1016/j.molmet.2014.12.010
,2014, 'Bariatric Surgery and Bone Loss: Do We Need to Be Concerned?', Clinical Reviews in Bone and Mineral Metabolism, 12, pp. 207 - 227, http://dx.doi.org/10.1007/s12018-014-9162-9
,2014, 'Neuropeptide Y attenuates stress-induced bone loss through suppression of noradrenaline circuits', Journal of Bone and Mineral Research, 29, pp. 2238 - 2249, http://dx.doi.org/10.1002/jbmr.2205
,2014, 'Neuropeptide Y Y-1 receptor antagonism: a novel anabolic tool for bone regeneration', JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 8, pp. 81 - 82, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000337612600148&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'The role of neuropeptide Y Y1 receptor signalling in fracture healing', Bone Abstracts, http://dx.doi.org/10.1530/boneabs.3.oc1.6
,2014, 'Pancreatic polypeptide controls energy homeostasis via Npy6r signaling in the suprachiasmatic nucleus in mice', Cell Metabolism, 19, pp. 58 - 72, http://dx.doi.org/10.1016/j.cmet.2013.11.019
,2014, 'Double deletion of orexigenic neuropeptide Y and dynorphin results in paradoxical obesity in mice', Neuropeptides, 48, pp. 143 - 151, http://dx.doi.org/10.1016/j.npep.2014.03.001
,2014, 'Stress- and diet-induced fat gain is controlled by NPY in catecholaminergic neurons', Molecular Metabolism, 3, pp. 581 - 591, http://dx.doi.org/10.1016/j.molmet.2014.05.001
,2014, 'The hunger games of skeletal metabolism', Bonekey Rep, 3, pp. 588, http://dx.doi.org/10.1038/bonekey.2014.83
,2013, 'Lack of CD47 impairs bone cell differentiation and results in an osteopenic phenotype in vivo due to impaired signal regulatory protein α (SIRPα) signaling', Journal of Biological Chemistry, 288, pp. 29333 - 29344, http://dx.doi.org/10.1074/jbc.M113.494591
,2013, 'Neuropeptide y modulates fracture healing through Y
2013, 'Influence of hormonal appetite and energy regulators on bone', Current Osteoporosis Reports, 11, pp. 194 - 202, http://dx.doi.org/10.1007/s11914-013-0157-0
,2013, 'Neuropeptide Y and Bone Formation', , pp. 39 - 49, http://dx.doi.org/10.1016/B978-0-12-415784-2.00004-X
,2013, 'Neuropeptide Y and Bone Regulation', , pp. 81 - 89, http://dx.doi.org/10.1016/B978-0-12-387829-8.00006-8
,2013, 'Erratum: Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN (Cell Metabolism 17 (236-248))', Cell Metabolism, 18, pp. 144, http://dx.doi.org/10.1016/j.cmet.2013.06.012
,2013, 'Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN', Cell Metabolism, 17, pp. 236 - 248, http://dx.doi.org/10.1016/j.cmet.2013.01.006
,2013, 'Bariatric surgery, bone loss, obesity and possible mechanisms', Obesity Reviews, 14, pp. 52 - 67, http://dx.doi.org/10.1111/j.1467-789X.2012.01050.x
,2013, 'Neuropeptide y is a critical modulator of Leptin's regulation of cortical bone', Journal of Bone and Mineral Research, 28, pp. 886 - 898, http://dx.doi.org/10.1002/jbmr.1786
,2013, 'Neuropeptide Y mediates the short-term hypometabolic effect of estrogen deficiency in mice', International Journal of Obesity, 37, pp. 390 - 398, http://dx.doi.org/10.1038/ijo.2012.71
,2012, 'A Murine Model of Neurofibromatosis Type 1 Tibial pseudarthrosis featuring proliferative fibrous tissue and osteoclast-like cells', Journal of Bone and Mineral Research, 27, pp. 68 - 78, http://dx.doi.org/10.1002/jbmr.528
,2012, 'Central and peripheral mechanisms of the NPY system in the regulation of bone and adipose tissue', Bone, 50, pp. 430 - 436, http://dx.doi.org/10.1016/j.bone.2011.10.001
,2012, 'Deletion of beta-adrenergic receptor 1, 2, or both leads to different bone phenotypes and response to mechanical stimulation', Journal of Bone and Mineral Research, 27, pp. 1252 - 1262, http://dx.doi.org/10.1002/jbmr.1594
,2012, 'Inhibition of sclerostin by systemic treatment with sclerostin antibody enhances healing of proximal tibial defects in ovariectomized rats', Journal of Orthopaedic Research, 30, pp. 1541 - 1548, http://dx.doi.org/10.1002/jor.22109
,2012, 'Neuropeptide Y Y1 receptor antagonism increases bone mass in mice', Bone, 51, pp. 8 - 16, http://dx.doi.org/10.1016/j.bone.2012.03.020
,2012, 'NPY modulates PYY function in the regulation of energy balance and glucose homeostasis', Diabetes Obesity and Metabolism, 14, pp. 727 - 736, http://dx.doi.org/10.1111/j.1463-1326.2012.01592.x
,2012, 'Peptide YY regulates bone remodeling in mice: a link between gut and skeletal biology', PLoS One, 7, pp. e40038, http://dx.doi.org/10.1371/journal.pone.0040038
,2012, 'The endogenous opioid dynorphin is required for normal bone homeostasis in mice', Neuropeptides, 46, pp. 383 - 394, http://dx.doi.org/10.1016/j.npep.2012.08.010
,2012, 'The NPY System and its Neural and Neuroendocrine Regulation of Bone', Current Osteoporosis Reports, 10, pp. 160 - 168, http://dx.doi.org/10.1007/s11914-012-0102-7
,2012, 'Y1 and y5 receptors are both required for the regulation of food intake and energy homeostasis in mice', PLoS ONE, 7, pp. e40191, http://dx.doi.org/10.1371/journal.pone.0040191
,2011, 'Pressure ulcer prevention program: A journey', Journal of Wound, Ostomy and Continence Nursing, 38, pp. 505 - 513, http://dx.doi.org/10.1097/WON.0b013e31822ad2ab
,2011, 'Distal tibial fracture repair in a neurofibromatosis type 1-deficient mouse treated with recombinant bone morphogenetic protein and a bisphosphonate', Journal of Bone and Joint Surgery - British Volume, 93 B, pp. 1134 - 1139, http://dx.doi.org/10.1302/0301-620X.93B8.25940
,2011, 'Peripheral specific Y2 receptor knockdown protects mice from high fat diet induced obesity', Obesity, 19, pp. 2137 - 2148, http://dx.doi.org/10.1038/oby.2011.99
,2011, 'Reciprocal regulation of bone and energy metabolism', Hormone Research in Paediatrics, 76, pp. 7 - 11, http://dx.doi.org/10.1159/000329134
,2010, 'Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation', Diabetes Obesity and Metabolism, 12, pp. 591 - 603
,2010, 'Are osteoclasts needed for the bone anabolic response to parathyroid hormone?: a study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL', The Journal of Biological Chemistry, 285, pp. 28164 - 28173, http://dx.doi.org/10.1074/jbc.M110.101964
,2010, 'Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity', Journal of Bone and Mineral Research, 25, pp. 1736 - 1747
,2010, 'Gastrointestinal peptides and bone health', Current Opinion in Endocrinology and Diabetes, 17, pp. 44 - 50
,2010, 'Hypothalamic regulation of bone', Journal of Molecular Endocrinology, 45, pp. 175 - 181, http://dx.doi.org/10.1677/JME-10-0015
,2010, 'In vivo local co-delivery of recombinant human bone morphogenetic protein-7 and pamidronate via poly-D, L-latic acid', European Cells and Materials, 20, pp. 431 - 442
,2010, 'Neuropeptide Y and sex hormone interactions in humoral and neuronal regulation of bone and fat', Trends in Endocrinology and Metabolism, 21, pp. 411 - 418
,2010, 'NPY neuron-specific Y2 receptors regulate adipose tissue and trabecular bone but not cortical bone homeostasis in mice', PLoS One, 5, pp. e11361, http://dx.doi.org/10.1371/journal.pone.0011361
,2010, 'Peripheral neuropeptide Y Y1 receptors regulate lipid oxidation and fat accretion', International journal of obesity, 34, pp. 357 - 373, http://dx.doi.org/10.1038/ijo.2009.232
,2010, 'Rapid cell culture and pre-clinical screening of a transforming growth factor-beta (TGF-beta) inhibitor for orthopaedics', BMC Musculoskelet Disord, 11, pp. 105, http://dx.doi.org/10.1186/1471-2474-11-105
,2010, 'Treatment of congenital pseudarthrosis of the tibia using recombinant bone morphogenetic protein and bisphosphonates', Bone, 46, pp. S20 - S21, http://dx.doi.org/10.1016/j.bone.2010.01.038
,2010, 'Y2 and Y4 receptor signalling synergistically act on energy expenditure and physical activity', American Journal of Physiology, 299, pp. 1618 - 1628
,2009, 'Critical interplay between neuropeptide Y and sex steroid pathways in bone and adipose tissue homeostasis', Journal of Bone and Mineral Research, 24, pp. 294 - 304
,2009, 'Neuropeptide Y is expressed by osteocytes and can inhibit osteoblastic activity', Journal of Cellular Biochemistry, 108, pp. 621 - 630
,2009, 'Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight', PLoS Clinical Trials, 4, pp. e8415 - e
,